A triple-hormone agonist acting on GIP, GLP-1, and glucagon receptors to promote significant weight loss and improve metabolic health by reducing appetite and increasing energy expenditure, showing promise in trials with average weight loss over 20%Description
🧬 Retatrutide
Reta
trutide is a synthetic research peptide developed for advanced scientific and laboratory investigations. It is primarily studied for its unique triple-receptor activity involving GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors.
Due to this multi-pathway interaction, Retatrutide has become a key subject of interest in experimental metabolic and endocrine signaling research. In controlled research environments, it is explored for its role in complex hormone signaling coordination and energy regulation pathways.
Experimental research involving Retatrutide commonly focuses on:
-
Multi-receptor signaling interactions
-
Peptide-driven metabolic pathway modulation
-
Appetite and energy expenditure signaling research
-
Endocrine and glucagon-related pathway studies
This product is produced under strict quality standards and supplied in multiple milligram variations to support diverse research protocols and controlled experimental designs.
Retatrutide offered by Johnson Peptides is intended strictly for in-vitro research, laboratory analysis, and scientific investigation by qualified professionals.
Available Variations
-
5mg
-
10mg
-
15mg
-
20mg
-
30mg
Product Specifications
-
Peptide Type: Synthetic Research Peptide
-
Form: Lyophilized Powder
-
Purity: ≥99% (HPLC verified)
-
Application: Research & Laboratory Use Only
